LifeTech Scientific (HKSE:01302) 5-Year EBITDA Growth Rate : 8.00% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific 5-Year EBITDA Growth Rate?

LifeTech Scientific's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.01.

During the past 12 months, LifeTech Scientific's average EBITDA Per Share Growth Rate was -45.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -11.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of LifeTech Scientific was 54.90% per year. The lowest was -11.40% per year. And the median was 15.30% per year.

Competitive Comparison of LifeTech Scientific's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, LifeTech Scientific's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeTech Scientific's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's 5-Year EBITDA Growth Rate falls into.

LifeTech Scientific 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

LifeTech Scientific (HKSE:01302) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

LifeTech Scientific 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeTech Scientific (HKSE:01302) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

LFTSF:USA 81X:Germany

Address

No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063

Website

http://www.lifetechmed.com

LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

Executives

Xie Yuehui	2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited	2101 Beneficial owner
Hhlr Advisors, Ltd.	2102 Investment manager
Bank Of Communications Trustee Limited	2301 Trustee
Xie Yuehui	2201 Interest of corporation controlled by you
Hhlr Fund, L.p.	2101 Beneficial owner
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines